Early IL-33 administration effect on body weight, SM damage and total Tregs pool. by Santiago Boccardo (5927954)

Subjects:

Tregs frequency is reduced in lymphoid and non-lymphoid target tissues during acute <i>T</i>. <i>cruzi</i> infection. by Santiago Boccardo (5927954)

Subjects:

IFN-γ limits trTreg expansion both <i>in vitro</i> after IL-33 stimulation and <i>in vivo</i> during <i>T</i>. <i>cruzi</i> infection. by Santiago Boccardo (5927954)

Subjects:

Inflammatory and microbial-derived signals are unable to restrict IL-33 mediated expansion of trTregs <i>in vitro</i>. by Santiago Boccardo (5927954)

Subjects:

IL-33 supplementation fails to prevent trTreg reduction in established <i>T</i>. <i>cruzi</i> infection. by Santiago Boccardo (5927954)

Subjects:

ST2+ KLRG-1+ Tregs from <i>T</i>. <i>cruzi</i> infected mice exhibit a phenotype compatible with <i>bona fide</i> trTregs. by Santiago Boccardo (5927954)

Subjects:

Autophagic flux decreased in an age-dependent manner in the heart. by Julian M. Carosi (9407082)

RDA and pearson correlation analysis of soil bacterial communities and soil environmental factors. by Jun Sun (48981)

Subjects:

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Cardiac performance and hemolymph distribution are significantly reduced upon valve malformation. by Christian Meyer (6035)

Summary of significant treatment × time effect. by Wensheng Xiao (16557866)

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.</p>…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.</p>…”

Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. by Chen Lu (135200)

Effect of BM-MSCs in improving DCS induced lung injury. by Chen Lu (135200)

Compression index of improved red clay. by Quan Shen (37564)

Subjects:

Compressibility modulus of improved red clay. by Quan Shen (37564)

Subjects:

Compressive strain of improved red clay. by Quan Shen (37564)

Subjects: